Life Sciences and Emerging Growth Businesses — Segment net sales

Corning Life Sciences and Emerging Growth Businesses — Segment net sales remained flat by 0.0% to $272.00M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2025

Last reportedQ1 2026

How to read this metric

An increase suggests successful product adoption and market expansion, while a decrease may indicate slowing demand or product lifecycle maturity.

Detailed definition

This metric represents the total revenue generated by the Life Sciences and Emerging Growth segment, which focuses on la...

Peer comparison

Comparable to revenue metrics for specialized life science tools or R&D-heavy business units in diversified industrial firms.

Metric ID: glw_segment_life_sciences_and_emerging_growth_businesses_segment_net_sales

Historical Data

2 periods

	Q1 '25	Q1 '26
Value	$272.00M	$272.00M
QoQ Change	—	+0.0%
YoY Change	—	+0.0%

Range$272.00M – $272.00M

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Similar Metrics at Other Companies

DanaherDHR View metric

Thermo Fisher ScientificTMO View metric

EcolabECL View metric

Thermo Fisher ScientificTMO View metric

Frequently Asked Questions

What is Corning's life sciences and emerging growth businesses — segment net sales?: Corning (GLW) reported life sciences and emerging growth businesses — segment net sales of $272.00M in Q1 2026.
What does life sciences and emerging growth businesses — segment net sales mean?: Total revenue earned from the Life Sciences and Emerging Growth business segment.